Summary:
- This article discusses the results of a Phase 3 clinical trial for a new hair loss drug called clascoterone, developed by Cosmo Pharmaceuticals.
- The trial showed that clascoterone was effective in treating male pattern baldness, with participants experiencing significant hair growth compared to those who received a placebo.
- The drug works by blocking the effects of dihydrotestosterone (DHT), a hormone that contributes to hair loss in both men and women, making it a promising new treatment option for those struggling with this common condition.